Medical University of South Carolina, Division of Rheumatolgoy and Immunology — Charleston, South Carolina

Medical University of South Carolina, Division of Rheumatolgoy and Immunology is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina, Division of Rheumatolgoy and Immunology has participated in 1 clinical trials.

Therapeutic areas: Systemic Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina, Division of Rheumatolgoy and Immunology?

Medical University of South Carolina, Division of Rheumatolgoy and Immunology has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina, Division of Rheumatolgoy and Immunology conducted?

Medical University of South Carolina, Division of Rheumatolgoy and Immunology has 1 clinical trials on record. Their work covers Systemic Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension.

Is Medical University of South Carolina, Division of Rheumatolgoy and Immunology accredited by Crixeo Health?

Medical University of South Carolina, Division of Rheumatolgoy and Immunology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina, Division of Rheumatolgoy and Immunology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.